Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Resistance and Resistin in HCV Patients Treated with DAAs
NCT04457050Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Oct 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sofosbuvir, ledipasvir, daclatasvir in hepatitis C (HCV), sponsored by Alexandria University. Started Oct 2017; status: completed.
02
Drugs
sofosbuvirledipasvirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04457050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04457050.